Zobrazeno 1 - 10
of 55
pro vyhledávání: '"Dov Sulitzeanu"'
Publikováno v:
Tissue Antigens. 7:129-144
Antibodies purified from sera of patients with Burkitt's lymphoma by absorption onto and elution from cultured lymphoblastoid cells, were labeled with 125I and repurified by repeating the absorption-elution procedure. The doubly purified antibodies c
Autor:
Sigurbjörg Torsteinsdóttir, Dov Sulitzeanu, George Klein, Pedro O. De Campos-Lima, Maria G. Masuccii, Laura Cuomo
Publikováno v:
Scopus-Elsevier
Burkitt's-lymphoma (BL) lines which have maintained in vitro the tumor-cell phenotype (group-I BLs) are poor antigen-presenting cells (APC), in spite of a relatively high surface expression of MHC class II. In order to investigate the mechanism of th
Autor:
Dov Sulitzeanu, Sarit Larisch-Bloch
Publikováno v:
Growth Factors. 8:177-186
We showed in previous work that LAK cell supernatants contain a large molecular weight factor with toxic activity for A375 melanoma and other cell lines. The factor, Fr1, was identified tentatively as TGF beta-related, since its activity was abolishe
Publikováno v:
Immunology Letters. 26:189-192
Supernatants of lymphokine-activated killer (LAK) cells were highly cytotoxic for melanoma A375 cells. A high-molecular-weight fraction was isolated from such supernatants by gel filtration on an S-300 Sephacryl column (Fraction 1; Fr1). The cytotoxi
Publikováno v:
Immunology letters. 33(2)
A375 human melanoma cell cultures grown in the presence of TGF beta contained greatly reduced cell numbers and exhibited drastic alterations in cell morphology compared to the control cultures. Preincubation of the cells with the cytokine for only 18
Autor:
Dov Sulitzeanu
Publikováno v:
Advances in Cancer Research ISBN: 9780120066605
Publisher Summary This chapter reviews the factors on immunosuppressive molecules that are elaborated by tumor cells or found in sera and effusions. Immunosuppressive factors can be found in normal sera, but their level is increased in cancer sera. T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0bf5987f4df59ec228a78c65293b1c53
https://doi.org/10.1016/s0065-230x(08)60827-1
https://doi.org/10.1016/s0065-230x(08)60827-1
Publikováno v:
Clinical immunology and immunopathology. 54(1)
An unusually heavy load of Epstein—Barr virus (EBV) infection and autoimmunity to collagen are believed to be contributing factors to the pathogenesis of rheumatoid arthritis (RA). The present report presents data showing that p107, the major epito
Autor:
Dov Sulitzeanu
Publikováno v:
Clinical Immunology Newsletter. 8:53-56
Autor:
George Klein, Ola Weiland, Joakim Dillner, Gertrude Henle, Kevin Hennessy, Werner Henle, Dov Sulitzeanu, Robert Szigeti, Elliott Kieff, Laszlo Timar
Publikováno v:
Clinical Immunology and Immunopathology. 41:342-350
Cell-mediated immune response of mononucleosis (IM) patients to Epstein-Barr virus (EBV)-determined antigens was measured by the leukocyte migration inhibition (LMI) assay. Patients in the acute phase of the disease failed to respond to partially pur
Publikováno v:
European Journal of Cancer and Clinical Oncology. 17:1165-1176
Immune complexes (IC) were isolated from sera of patients with breast cancer (BC), from effusions from patients with breast and ovarian cancer (OC) and from effusions from patients with non-malignant diseases. Isolation was carried out with the aid o